| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
,
* National Center for Rehabilitative Auditory Research and Department of Immunology, Veterans Affairs Medical Center, Portland, OR 97239;
Targeted Gene Delivery, Inc., Portland, OR 97201; and
Department of Otolaryngology, and
Department of Medicine, Division of Rheumatology, Oregon Health and Science University, Portland, OR 97239
TLRs recognize and respond to conserved motifs termed pathogen-associated molecular patterns. TLRs are characterized by an extracellular leucine-rich repeat motif and an intracellular Toll/IL-1R domain. Triggering of TLRs by pathogen-associated molecular patterns initiates a series of intracellular signaling events resulting in an inflammatory immune response designed to contain and eliminate the pathogen. Vaccinia virus encodes immunoregulatory proteins, such as A52R, that can effectively inhibit intracellular Toll/IL-1R signaling, resulting in a diminished host immune response and enhancing viral survival. In this study, we report the identification and characterization of a peptide derived from the A52R protein (sequence DIVKLTVYDCI) that, when linked to the nine-arginine cell transduction sequence, effectively inhibits cytokine secretion in response to TLR activation. The peptide had no effect on cytokine secretion resulting from cell activation that was initiated independent of TLR stimulation. Using a mouse model of otitis media with effusion, administration of heat-inactivated Streptococcus pneumoniae into the middle ears of BALB/c mice resulted in a significant inflammatory response that was dramatically reduced with peptide treatment. The identification of this peptide that selectively targets TLR-dependent signaling may have application in the treatment of chronic inflammation initiated by bacterial or viral infections.
This article has been cited by other articles:
|
|
 |
|
  D. Chiavolini, G. Pozzi, and S. Ricci Animal Models of Streptococcus pneumoniae Disease Clin. Microbiol. Rev., October 1, 2008; 21(4): 666 - 685. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Garcel, J.-M. Crance, R. Drillien, D. Garin, and A.-L. Favier Genomic sequence of a clonal isolate of the vaccinia virus Lister strain employed for smallpox vaccination in France and its comparison to other orthopoxviruses J. Gen. Virol., July 1, 2007; 88(7): 1906 - 1916. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. J. Leppert, J. M. Mansfield, and D. M. Paulnock The Soluble Variant Surface Glycoprotein of African Trypanosomes Is Recognized by a Macrophage Scavenger Receptor and Induces I{kappa}B{alpha} Degradation Independently of TRAF6-Mediated TLR Signaling J. Immunol., July 1, 2007; 179(1): 548 - 556. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Deng, P. Dai, W. Ding, R. D. Granstein, and S. Shuman Vaccinia virus infection attenuates innate immune responses and antigen presentation by epidermal dendritic cells. J. Virol., October 1, 2006; 80(20): 9977 - 9987. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Maloney, M. Schroder, and A. G. Bowie Vaccinia Virus Protein A52R Activates p38 Mitogen-activated Protein Kinase and Potentiates Lipopolysaccharide-induced Interleukin-10 J. Biol. Chem., September 2, 2005; 280(35): 30838 - 30844. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
